Registration - Consultant

National Institute for Pharmaceutical Research and Development / Luwam Ghebre, Consultant

Registration Information

Client name: National Institute for Pharmaceutical Research and Development
Lobbyist name: Luwam Ghebre, Consultant
Initial registration start date: 2021-06-14
Registration status: Inactive
Registration Number: 948047-369699

Associated Communications

Total Number of Communication Reports: 0

Monthly communication reports in the last 6 months: 0

Version 1 of 1 (2021-06-14 to 2022-05-17)

Lobbying Information

Subject Matters

International Development
Research and Development
Science and Technology

Subject Matter Details

Grant, Contribution or Other Financial Benefit

Mobilize resources from the government to support the institute’s efforts in improving sustainable access to safe, high-quality and affordable healthcare in Africa, through local production of medicines and commodities.

Communication Techniques

Written communication
Oral communication

The lobbyist has arranged or expects to arrange one or more meetings on behalf of the client between a public office holder and any other person in the course of this undertaking.

Government Institutions

Global Affairs Canada (GAC)

Client Details

Government funding

End date of the last completed financial year: 2020-12-31

List of Government Funding
Government Institution	Funding Received in Last Financial Year	Funding Expected in Current Financial Year
Federal Government of Nigeria	$600,000.00	Yes

Client Contact Information

Address:
Plot 942, Cadastral Zone C16, Idu
Industrial District
Abuja n/a
Nigeria

Telephone number: +234 90 000 0000
Web address: https://www.niprd.gov.ng

Client representative

Dr. Obi Peter Adigwe, Director General/Chief Executive Officer

Parent Company Information

National Institute for Pharmaceutical Research and Development is not a subsidiary of any other parent companies.

Coalition Members Information

National Institute for Pharmaceutical Research and Development is not a coalition.

Individual, organization or corporation with a Direct Interest Beneficiary Information

The activities of National Institute for Pharmaceutical Research and Development are not controlled or directed by another individual, organization or corporation with a direct interest in the outcome of this undertaking.

Subsidiary Beneficiary Information

National Institute for Pharmaceutical Research and Development does not have any subsidiaries that could have a direct interest in the outcome of the undertaking

Lobbyist Details

Luwam Ghebre | Public offices held

Business address:
800-1600 Carling Avenue
Ottawa, ON K1Z 1G3
Canada

Telephone number: 514-758-5672

Consultant Firm and Address

Firm: Wellington Advocacy

Address:
800-1600 Carling Avenue
Ottawa, ON K1Z 1G3
Canada

Telephone number: 514-758-5672

National Institute for Pharmaceutical Research and Development/

The following names have been used on or after July 2, 2008

The following names have been used on or after July 2, 2008
Name	From	To
National Institute for Pharmaceutical Research and Development/	2021-06-14	2022-05-17

National Institute for Pharmaceutical Research and Development

Responsible Officer History
Responsible Officer Name	From (YYYY-MM-DD)	To (YYYY-MM-DD)

List of Public Offices Held
Position	Period Held	Last Date Designated Public Office Held
Committees Coordinator House of Commons, Chief Opposition Whip	October 2015 to February 2019	Not a designated office
Committees Coordinator House of Commons, Chief Government Whip	September 2013 to October 2015	Not a designated office

List of Public Offices Held
Position	Period Held	Last Date Designated Public Office Held
Committees Coordinator House of Commons, Chief Opposition Whip	October 2015 to February 2019	Not a designated office
Committees Coordinator House of Commons, Chief Government Whip	September 2013 to October 2015	Not a designated office

Date Modified:: 2024-04-04

Search and menus

Language selection

Registration - Consultant

National Institute for Pharmaceutical Research and Development / Luwam Ghebre, Consultant

Registration Information

Associated Communications

Version 1 of 1 (2021-06-14 to 2022-05-17)

Version 1 of 1 (2021-06-14 to 2022-05-17)

Subject Matters

Subject Matter Details

Grant, Contribution or Other Financial Benefit

Communication Techniques

Government Institutions

Government funding

Client Contact Information

Client representative

Parent Company Information

Coalition Members Information

Individual, organization or corporation with a Direct Interest Beneficiary Information

Subsidiary Beneficiary Information

Consultant Firm and Address

Registration - Consultant

National Institute for Pharmaceutical Research and Development / Luwam Ghebre, Consultant

Version 1 of 1 (2021-06-14 to 2022-05-17)

Subject Matters

Subject Matter Details

Grant, Contribution or Other Financial Benefit

Communication Techniques

Government Institutions

Government funding

Client Contact Information

Client representative

Parent Company Information

Coalition Members Information

Individual, organization or corporation with a Direct Interest Beneficiary Information

Subsidiary Beneficiary Information

Consultant Firm and Address

National Institute for Pharmaceutical Research and Development/

The following names have been used on or after July 2, 2008

National Institute for Pharmaceutical Research and Development

Luwam Ghebre, Wellington Advocacy (Consultant)